Call for projects Ferring

Call for innovative projects

FERRING

Make a breakthrough in the pharmaceutical industry

Selection completed

We are looking for innovations
in reproductive medicine to increase the quality of life for people around the world

Ferring Pharmaceuticals

A leading manufacturer of peptide hormones

Ferring was among the first to develop pharmaceuticals based on natural peptide hormones produced by hypophysis

11 R&D centers

China, Denmark, India, USA, Scotland, Israel, Switzerland

10+ pharmaceuticals

Launched in the Russian market in three areas: ART and Obstetrics, Urology, and Gastroenterology

Benefits for participants

Grants for project development

Internships and access to Ferring research labs

The most promising projects will be invited to discuss opportunities for partnership with Ferring

What are we looking for?

Projects at early* and later stages in Reproductive Health and Fertility

* Pre-clinical research or MVP (minimum viable product)

Male infertility

Female infertility

Sexual dysfunction

Obstetrics

Preeclampsia

Microbiota

Ageing and Anti-ageing

Scope for selection

New peptides

New delivery systems for existing peptides

New monoclonal antibodies

Microbiome research

New formulations for existing drugs

New diagnostic instruments (infertility, premature birth)

Nasal delivery

Medical genetics and genomics

Big data in reproductive health / fertility

Schedule

September 16, 2019

Application deadline

October 16, 2019

Assessment

March 31, 2020

Result publication

Experts

Gennadiy Sukhikh

RAS Academician, Director of National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Dmitry Pushkar

RAS Corresponding member, Chief urologist for Ministry of Health of Russia, Head of Urology Clinic (City Clinical Hospital named after S.I. Spasokukotsky, GKB 50)

Vladislav Korsak

Doctor of medical science, professor, General Director of International Centre for Reproductive Medicine, President of Russian Association of Human Reproduction

Oleg Apolikhin

RAS Corresponding member, Director of Research Institute of Urology and Interventional Radiology n.a. N.A. Lopatkin, Chief specialist for Ministry of Health of Russia on reproductive health

Roman Kozlov

RAS Corresponding member, Chief specialist for Ministry of Health of Russia on clinical microbiology and antimicrobial resistance

Alexander Majouga

RAS Professor, Rector of D. Mendeleev University of Chemical Technology of Russia

Andrey Melnikov

Head of the Department of Science, Technology and Education of the Embassy of Switzerland in Russia

Kirill Litovchenko

General Manager Ferring Pharmaceuticals Russia and Eurasia

Alan Harris

Senior Vice President Global R&D Projects Ferring Pharmaceuticals

Lionel Pidoux

Senior Global Project Director for Global Research & Development, Global Life Cycle Management at Ferring Pharmaceuticals

Julia Vlasenko

Senior Manager Laboratory Ferring Pharmaceuticals Russia and Eurasia

Ekaterina Petrova

Director of GenerationS Corporate Accelerator

Anatoly Borodin

Manager at GenerationS
Corporate Accelerator

F.A.Q.

Do I have to share confidential data about my project?

No. Please disclose in your application only the information that can be shared without signing an NDA.

Does the selection involve only projects from Russia?

No. We invite projects from all over the world that fit the criteria to take part in the selection.

I represent 2 projects. Can I submit multiple applications?

Yes, you are welcome to submit two applications. Please register a second account on our website and apply with your second project.

Can I meet you in person and receive feedback on my project?

Occasionally, the accelerator team takes part in partner events and organizes own #GENSTalks, where you can approach the team members for consultation. Follow us on our website and in social media for updates.